Millie D. Long

12.3k total citations · 3 hit papers
271 papers, 8.1k citations indexed

About

Millie D. Long is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, Millie D. Long has authored 271 papers receiving a total of 8.1k indexed citations (citations by other indexed papers that have themselves been cited), including 174 papers in Genetics, 146 papers in Epidemiology and 92 papers in Surgery. Recurrent topics in Millie D. Long's work include Inflammatory Bowel Disease (172 papers), Microscopic Colitis (106 papers) and Eosinophilic Esophagitis (52 papers). Millie D. Long is often cited by papers focused on Inflammatory Bowel Disease (172 papers), Microscopic Colitis (106 papers) and Eosinophilic Esophagitis (52 papers). Millie D. Long collaborates with scholars based in United States, Canada and Germany. Millie D. Long's co-authors include Michael D. Kappelman, Robert S. Sandler, Christopher F. Martin, Hans Herfarth, Ashwin N. Ananthakrishnan, Corey A. Siegel, David T. Rubin, Bryan G. Sauer, Edward L. Barnes and Mark Pimentel and has published in prestigious journals such as Gastroenterology, Gut and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Millie D. Long

247 papers receiving 7.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

ACG Clinical Guideline: Ulcerative Colitis in Adults

2019 1.0k citations Ashwin N. Ananthakrishnan, Millie D. Long et al. The American Journal of Gastroenterology profile →
ACG Clinical Guideline: Management of Irritable Bowel Syndrome

2020 488 citations Millie D. Long et al. The American Journal of Gastroenterology profile →
Acute-on-Chronic Liver Failure Clinical Guidelines

2022 117 citations Millie D. Long et al. The American Journal of Gastroenterology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Millie D. Long United States	45	4.6k	3.8k	2.3k	1.4k	918	271	8.1k
Johan Burisch Denmark	41	5.1k 1.1×	3.6k 1.0×	2.2k 1.0×	910 0.6×	991 1.1×	233	7.6k
James O. Lindsay United Kingdom	47	5.4k 1.2×	3.8k 1.0×	2.4k 1.0×	1.3k 0.9×	1.3k 1.4×	215	9.2k
Pia Munkholm Denmark	40	5.3k 1.2×	4.0k 1.1×	2.5k 1.1×	952 0.7×	842 0.9×	110	7.2k
Richard B. Gearry New Zealand	52	4.5k 1.0×	3.2k 0.9×	2.5k 1.1×	1.5k 1.1×	1.2k 1.3×	311	9.5k
Hamed Khalili United States	47	4.2k 0.9×	4.0k 1.1×	2.1k 0.9×	1.1k 0.8×	690 0.8×	220	8.2k
Jean–Frédéric Colombel France	35	7.0k 1.5×	5.5k 1.5×	2.7k 1.2×	951 0.7×	1.6k 1.8×	75	8.9k
Michael D. Kappelman United States	51	5.6k 1.2×	4.6k 1.2×	4.2k 1.8×	1.3k 0.9×	1.1k 1.2×	282	11.6k
Johanna C. Escher Netherlands	40	4.0k 0.9×	2.7k 0.7×	2.2k 1.0×	808 0.6×	1.2k 1.3×	164	6.9k
John K MacDonald Canada	46	4.1k 0.9×	3.2k 0.8×	1.9k 0.8×	645 0.5×	721 0.8×	135	6.6k
Bjørn Moum Norway	48	6.8k 1.5×	5.9k 1.6×	3.4k 1.5×	1.1k 0.8×	1.2k 1.3×	179	9.7k

Countries citing papers authored by Millie D. Long

Since Specialization

Citations

This map shows the geographic impact of Millie D. Long's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Millie D. Long with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Millie D. Long more than expected).

Fields of papers citing papers by Millie D. Long

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Millie D. Long. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Millie D. Long. The network helps show where Millie D. Long may publish in the future.

Co-authorship network of co-authors of Millie D. Long

This figure shows the co-authorship network connecting the top 25 collaborators of Millie D. Long. A scholar is included among the top collaborators of Millie D. Long based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Millie D. Long. Millie D. Long is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Barnes, Edward L., Laura E. Raffals, Taha Qazi, et al.. (2025). A Prospective Comparison of Ustekinumab and Antitumor Necrosis Factor α Therapy in the Treatment of Crohn's-Like Disease of the Pouch. The American Journal of Gastroenterology.

Long, Millie D., Stefan Schreiber, Toshifumi Hibi∥, et al.. (2024). Association of Bowel Urgency With Quality-of-Life Measures in Patients With Moderately-to-Severely Active Ulcerative Colitis: Results From Phase 3 LUCENT-1 (Induction) and LUCENT-2 (Maintenance) Studies. Crohn s & Colitis 360. 6(1). otae001–otae001. 4 indexed citations

Long, Millie D., Sunanda V. Kane, Dawn B. Beaulieu, et al.. (2024). Mo1871 USE OF BIOSIMILARS TO INFLIXIMAB DURING PREGNANCY IN WOMEN WITH INFLAMMATORY BOWEL DISEASE. Gastroenterology. 166(5). S–1153. 4 indexed citations

Vermeire, Séverine, Jessica R. Allegretti, Millie D. Long, et al.. (2024). OP09 Oral ritlecitinib and brepocitinib in patients with moderate to severe active Crohn’s Disease: Data from the PIZZICATO umbrella study. Journal of Crohn s and Colitis. 18(Supplement_1). i16–i16. 3 indexed citations

Kayal, Maia, Elizabeth A. Spencer, Matthew D. Smyth, et al.. (2024). Risankizumab Is Effective for The Management of Crohn’s Disease of the Pouch. Inflammatory Bowel Diseases. 31(3). 878–881. 1 indexed citations

Cohen, Benjamin, et al.. (2024). Predicting Outcomes in Hospitalized Patients With Acute Severe Ulcerative Colitis in a Prospective Multicenter Cohort. Inflammatory Bowel Diseases. 31(6). 1548–1555. 2 indexed citations

Long, Millie D., Javier P. Gisbert, Kim McGinnis, et al.. (2023). IMPROVEMENT IN BOWEL URGENCY IS ASSOCIATED WITH STOOL FREQUENCY AND RECTAL BLEEDING REMISSION AT 12 AND 52 WEEKS IN PATIENTS WITH MODERATELY-TO-SEVERELY ACTIVE ULCERATIVE COLITIS. Inflammatory Bowel Diseases. 29(Supplement_1). S10–S11. 1 indexed citations

Brenner, Erica J., Li Lin, Millie D. Long, et al.. (2023). Computerized-adaptive testing versus short forms for pediatric inflammatory bowel disease patient-reported outcome assessment. Journal of Clinical and Translational Science. 7(1). e109–e109.

Kayal, Maia, Parakkal Deepak, Poonam Beniwal‐Patel, et al.. (2023). Changes in Therapy Are Not Associated With Increased Remission in Patients With Crohn's Disease of the Pouch. The American Journal of Gastroenterology. 119(3). 584–587. 4 indexed citations

10.

Barnes, Edward L., Poonam Beniwal‐Patel, Parakkal Deepak, et al.. (2023). Dietary Patterns Are Not Associated With Disease Activity Among Patients With Inflammatory Conditions of the Pouch in a Prospective Cohort. Crohn s & Colitis 360. 5(3). otad039–otad039. 1 indexed citations

11.

Sands, Bruce E., Brian G. Feagan, Theresa Hunter, et al.. (2023). Mirikizumab Improves Quality of Life in Patients With Moderately-to-Severely Active Ulcerative Colitis: Results From the Phase 3 LUCENT-1 Induction and LUCENT-2 Maintenance Studies. Crohn s & Colitis 360. 5(4). otad070–otad070. 8 indexed citations

12.

Herfarth, Hans, Anita Afzali, Monika Fischer, et al.. (2023). Clinical Long-Term Outcomes of Patient-Reported Outcomes in the Prospective Real-World Tofacitinib Response in Ulcerative Colitis Registry. Clinical and Translational Gastroenterology. 15(3). e00669–e00669. 1 indexed citations

13.

Axelrad, Jordan E., Millie D. Long, Sara Horst, et al.. (2022). A Novel Remote Patient and Medication Monitoring Solution to Improve Adherence and Persistence With Inflammatory Bowel Disease Therapy (ASSIST Study): Protocol for a Randomized Controlled Trial. JMIR Research Protocols. 11(12). e40382–e40382. 4 indexed citations

14.

Barnes, Edward L., Parakkal Deepak, Poonam Beniwal‐Patel, et al.. (2022). Treatment Patterns and Standardized Outcome Assessments Among Patients With Inflammatory Conditions of the Pouch in a Prospective Multicenter Registry. Crohn s & Colitis 360. 4(3). otac030–otac030. 9 indexed citations

15.

Chen, Ding‐Geng, et al.. (2021). Influencing Factors of Inflammatory Bowel Disease–Fatigue. Nursing Research. 70(4). 256–265. 10 indexed citations

16.

Hemperly, Amy, Marla C. Dubinsky, Andrés Yarur, et al.. (2021). Noninvasive Targeted Crohn Disease Management by Combining Endoscopic Healing Index and Therapeutic Drug Monitoring. Crohn s & Colitis 360. 3(3). otab035–otab035. 1 indexed citations

17.

Barnes, Edward L., Laura H. Raffals, Millie D. Long, et al.. (2020). Disease and Treatment Patterns Among Patients With Pouch-related Conditions in a Cohort of Large Tertiary Care Inflammatory Bowel Disease Centers in the United States. Crohn s & Colitis 360. 2(3). otaa039–otaa039. 8 indexed citations

18.

Barnes, Edward L., Bharati Kochar, Hans Herfarth, et al.. (2020). Creation of a Case-Finding Definition for Identifying Patients With Acute Pouchitis in Administrative Claims Data. Clinical Gastroenterology and Hepatology. 19(4). 842–844.e1. 10 indexed citations

19.

Cook, Suzanne F., Renee Bright, Meaghan Mallette, et al.. (2016). Achieving Synergy: Linking an Internet-Based Inflammatory Bowel Disease Cohort to a Community-Based Inception Cohort and Multicentered Cohort in Inflammatory Bowel Disease. Journal of Medical Internet Research. 18(6). e124–e124. 3 indexed citations

20.

Herfarth, Hans, Susan Jackson, Christopher Martin, et al.. (2016). Investigator-Initiated IBD Trials in the United States. Inflammatory Bowel Diseases. 23(1). 14–22. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact